Clinical trial and pharmaceutical logistics specialists at COREX Logistics have announced the appointment of Steve Healy as the organisation’s new CEO.
Healy, COREX Logistics’ former Vice President of Business Development, has been appointed CEO as the company looks to accelerate its global growth, expanding its operations and services.
Healy has more than 20 years of extensive expertise and leadership experience working within the pharmaceutical logistics sector with a focus on commercial pharmaceutical distribution and clinical trial supply chains.
READ: GIVING KOALAS THE VIP TREATMENT
In his new position Healy will oversee the long-established company’s vision for further future internationalising of the business with expansion into new markets, and continued development of operations in its traditional markets across Eastern Europe and Asia.
Healy said: “I welcome the trust the company has in me to lead the next phase of COREX’s journey. We will continue to evolve as a business and build on the company’s proven success to further develop our operations in patient centric services to meet the continually changing complex needs in clinical trials.
“Positive patient outcomes are paramount to the COREX Logistics team, and we will continue to also focus on our outstanding customer service delivery as we grow our business and invest in operational excellence.”
COREX Logistics Founder, Andrey Tarakanov, who will remain in the business to focus on specific projects, welcomed the appointment adding: “I am delighted Steve will be leading us through the next stage of our significant global growth. His experience in the specialist sector and deep understanding of our customer’s complex requirements mean he is the right leader to create substantial lasting growth for the business going forward.”
With extensive knowledge of Good Distribution Practise and complex temperature-controlled supply chain solutions, including airfreight, road freight and specialist courier services, Healy, who held previous leadership roles with va-Q-tec, Peli BioThermal and DGP Intelsius, has worked with pharmaceutical companies, central labs, and CROs to improve their logistics operations and supply chains. He also worked with public sector institutions in the rollout of COVID-19 vaccines and other public health initiatives.
